SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0001140361-06-004951
Filing Date
2006-03-31
Accepted
2006-03-31 16:20:52
Documents
11
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS 10KSB 12-31-2005 form10ksb.htm 10KSB 1332646
2 EXHIBIT 9 ex9.txt EX-9 48616
3 EXHIBIT 10.5 ex10_5.htm EX-10.5 85329
4 EXHIBIT 10.6 ex10_6.htm EX-10.6 243295
5 EXHIBIT 23.1 ex23_1.htm EX-23.1 3406
6 EXHIBIT 23.2 ex23_2.htm EX-23.2 3777
7 EXHIBIT 24 ex24.htm EX-24 17009
8 EXHIBIT 31.1 ex31_1.htm EX-31.1 13932
9 EXHIBIT 31.2 ex31_2.htm EX-31.2 13092
10 EXHIBIT 32.1 ex32_1.htm EX-32.1 8249
11 EXHIBIT 32.2 ex32_2.htm EX-32.2 8401
  Complete submission text file 0001140361-06-004951.txt   1779264
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-50590 | Film No.: 06729162
SIC: 2834 Pharmaceutical Preparations